Long-chain acylcarnitine 18:1 acutely increases human atrial myocardial contractility and arrhythmia susceptibility

Overview of attention for article published in American Journal of Physiology: Heart & Circulatory Physiology, June 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 3 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 27,369 followers.

RT @ajpheartcirc: Aitken-Buck and co-authors show *for the first time* that the fatty acid metabolite, long-chain acylcarnitine 18:1, acute…

Aitken-Buck and co-authors show *for the first time* that the fatty acid metabolite, long-chain acylcarnitine 18:1, acutely increases #arrhythmia susceptibility & contractility of human atrial myocardium https://t.co/pvxYtHGfb0 @otago https://t.co/…

RT @ajpheartcirc: #ArticlesInPress: Long-chain acylcarnitine 18:1 acutely increases human atrial myocardial contractility and arrhythmia su…

#ArticlesInPress: Long-chain acylcarnitine 18:1 acutely increases human atrial myocardial contractility and arrhythmia susceptibility (Aitken-Buck et al.) https://t.co/rGFsqI2Qft @hamishab7 @otago #LongChainAcylcarnitines #HumanTrabeculae #HEK293cells …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.